Skip to content

Management Of Klaibya With Special Reference To Erectile Dysfunction

An open label clinical trial to evaluate the efficacy of Vidangaadya Taila Uttar Basti and Pramehamihir Taila Upastha Basti followed by Amritprasha Ghrita in the management of Klaibya with special reference to Erectile Dysfunction - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070748
Enrollment
30
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N529- Male erectile dysfunction, unspecified

Interventions

None listed

Sponsors

National institute of ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age : 18 to 60 years 2 Gender : Male 3 Patients presenting with Samanya Lakshana of Klaibya (Erectile Dysfunction) 4 Unable to consummate the sexual act due to lack of erection, lack of rigidity at least 50% of coital instances. 5 Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: 1 Spinal cord injury. 2 Major organic or psychosomatic disorder. 3 Poorly controlled Diabetes mellitus, Severe Systemic diseases, Uncontrolled hypertension. 4 ED due to surgery of colon, prostate, bladder or rectum. 5 Carcinoma of penis. 6 Hypospadias. 7 Phimosis. 8 Patients with possible effects of any medication. 9 Patients with Venereal disease, HIV. 10 Congenital chordee 11 Congenital defect of genital organ

Design outcomes

Primary

MeasureTime frame
1.Changes in score of Patient Questionnaire from International Index of Erectile Function (IIEF) 2.Clinical Interpretation of Mlanashishnata- a. No erection at all b. Erection but not sustained c. Sustained erection d. Erection but not enough for penetration e. Erection enough for penetration Successful intercourseTimepoint: at baseline, after 2 weeks of treatment

Secondary

MeasureTime frame
The secondary outcome of the study will be assessed by changes of DSM V criteria score.Timepoint: after 4 weeks of complete treatment

Countries

India

Contacts

Public ContactProf Dr Gopesh mangal

National institute of ayurveda

Gopesh.pk@nia.edu.in8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026